IGFBP7 and acute kidney injury: Urine IGFBP7 has been approved as a marker by the US Food and Drug Administration for determining the risk of developing moderate-to-severe acute kidney injury (Vijayan et al., 2016), indicating that PTCs in Statue 6 are injured and inflammatory PTCs.